Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$73.27 - $83.09 $14,287 - $16,202
-195 Reduced 6.41%
2,847 $230,000
Q3 2023

Nov 07, 2023

BUY
$73.94 - $80.67 $295 - $322
4 Added 0.13%
3,042 $227,000
Q2 2023

Aug 09, 2023

SELL
$76.01 - $86.7 $4,864 - $5,548
-64 Reduced 2.06%
3,038 $234,000
Q1 2023

May 11, 2023

BUY
$77.31 - $88.08 $10,436 - $11,890
135 Added 4.55%
3,102 $257,000
Q4 2022

Feb 07, 2023

BUY
$62.32 - $89.47 $184,903 - $265,457
2,967 New
2,967 $254,000
Q2 2022

Aug 15, 2022

SELL
$57.72 - $65.01 $214,833 - $241,967
-3,722 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$57.92 - $72.58 $17,491 - $21,919
-302 Reduced 7.5%
3,722 $221,000
Q4 2021

Feb 11, 2022

BUY
$64.88 - $73.64 $34,516 - $39,176
532 Added 15.23%
4,024 $292,000
Q3 2021

Nov 15, 2021

BUY
$67.69 - $73.03 $203 - $219
3 Added 0.09%
3,492 $243,000
Q2 2021

Aug 13, 2021

SELL
$63.47 - $69.35 $5,712 - $6,241
-90 Reduced 2.51%
3,489 $240,000
Q1 2021

May 10, 2021

SELL
$60.0 - $68.46 $252,360 - $287,942
-4,206 Reduced 54.03%
3,579 $231,000
Q4 2020

Feb 11, 2021

BUY
$56.65 - $64.55 $441,020 - $502,521
7,785 New
7,785 $457,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Oder Investment Management, LLC Portfolio

Follow Oder Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oder Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oder Investment Management, LLC with notifications on news.